The 165 references in paper , статья Редакционная (2014) “Новая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществ // Novel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory Society” / spz:neicon:pulmonology:y:2013:i:5:p:9-24

1
American Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.
(check this in PDF content)
2
Travis W.D., Hunninghake G., King T.E. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–1347.
(check this in PDF content)
3
Aziz Z.A., Wells A.U., Hansell D.M. et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.
(check this in PDF content)
4
Flaherty K.R., King T.E. Jr, Raghu G. et al.Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904–910.
(check this in PDF content)
5
Nicholson A.G., Addis B.J., Bharucha H. et al. Interobserver variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500–505.
(check this in PDF content)
6
Thomeer M., Demedts M., Behr J. et al.Idiopathic Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 585–591.
(check this in PDF content)
7
Flaherty K.R., Andrei A.&C., King T.E. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054–1060.
(check this in PDF content)
8
Raghu G., Collard H.R., Egan J.J.et al. An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.
(check this in PDF content)
9
Selman M.Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin. Chest Med. 2004; 25: 531–547, vi.
(check this in PDF content)
10
Lynch D.A., Newell J.D., Logan P.M. et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? Am. J. Roentgenol. 1995; 165: 807–811.
(check this in PDF content)
11
Silva C.I., Churg A., Muller N.L. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am. J. Roentgenol. 2007; 188: 334–344.
(check this in PDF content)
12
Silva C.I.S., Muller N.L., Lynch D.A. et al.Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288–297. Таблица 4 Биомаркеры крови и БАЛ, прогнозирующие исход ИИП (более высокий уровень соответствует низкой выживаемости) БиомаркерБольныеОР (95 %!ный ДИ)рСсылка SP!AИЛФ (n= 52) (выжившие 0,0125[155] SP!Dпо сравнению с умершими)0,0032 SP!AИЛФ (n= 142)1,730,031[156] SP!D2,040,003 KL!6 (> 1 000 Ед. / мл)ИЛФ (n= 27)12,56 (1,195–131,90)0,035[157] KL!6 (≥ 1 000 Ед. / мл)ИИП (n= 152) и с заболе!2,95 (1,71–5,08)0,0001[129] ваниями сосудов при коллагенозах (n= 67) SP!D (≥253)ИЛФ (n= 82)0,0013[158] SP!A–НД KL!6 (> 1,014)–0,0087 Уровень окислитель!ИЛФ (n = 21)ФЖЕЛ:r=
(check this in PDF content)
13
Akashi T., Takemura T., Ando N. et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am. J. Clin. Pathol. 2009; 131: 405–415.
(check this in PDF content)
14
Churg A., Muller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2006; 30: 201–208.
(check this in PDF content)
15
Churg A., Sin D.D., Everett D. et al.Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765–1770.
(check this in PDF content)
16
Fenton M.E., Cockcroft D.W., Wright J.L., Churg A. Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann. Allergy Asthma Immunol. 2007; 99: 465–466.
(check this in PDF content)
17
Sahin H., Brown K.K., Curran&Everett D. et al.Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244: 591–598.
(check this in PDF content)
18
Hanak V., Golbin J.M., Ryu J.H.Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007; 82: 812–816.
(check this in PDF content)
19
Felicio C.H., Parra E.R., Capelozzi V.L. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung
(check this in PDF content)
20
7; 185: 39–46. 20.Park J.H., Kim D.S., Park I.N. et al.Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.
(check this in PDF content)
21
Hwang J.&H., Misumi S., Sahin H. et al.Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J. Comput. Assist. Tomogr. 2009; 33: 410–415.
(check this in PDF content)
22
Song J.W., Do K.&H., Kim M.&Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease–related usual interstitial pneumonia. Chest 2009; 136: 23–30.
(check this in PDF content)
23
Corte T.J., Copley S.J., Desai S.R. et al.Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661–668.
(check this in PDF content)
24
Suda T., Kono M., Nakamura Y. et al.Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527–1534.
(check this in PDF content)
25
Kinder B.W., Collard H.R., Koth L. et al.Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.
(check this in PDF content)
26
Garcia&Sancho C., Buendia&Roldan I., Fernandez&Plata M.R. et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 2011; 105: 1902–1907.
(check this in PDF content)
27
Hodgson U., Laitinen T., Tukiainen P.Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338–342.
(check this in PDF content)
28
Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.
(check this in PDF content)
29
Barlo N.P., van Moorsel C.H.M., Ruven H.J.T. et al. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2009; 26: 155–161.
(check this in PDF content)
30
Nogee L.M., Dunbar A.E. III, Wert S.E. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.
(check this in PDF content)
31
Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009; 1792: 371–379.
(check this in PDF content)
32
Moorsel C.H., van Oosterhout M.F., Barlo N.P. et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 1419–1425.
(check this in PDF content)
33
Alder J.K., Chen J.J.L., Lancaster L. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008; 105: 13051–13056.
(check this in PDF content)
34
Cronkhite J.T., Xing C., Raghu G. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729–737.
(check this in PDF content)
35
Lawson W.E., Crossno P.F., Polosukhin V.V. et al.Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L1119–L1126.
(check this in PDF content)
36
Seibold M.A., Wise A.L., Speer M.C. et al.A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503–1512.
(check this in PDF content)
37
Zhang Y., Noth I., Garcia J.G., Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576–1577.
(check this in PDF content)
38
Lawson W.E., Loyd J.E., Degryse A.L. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439–443.
(check this in PDF content)
39
Monaghan H., Wells A.U., Colby T.V. et al.Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522–526.
(check this in PDF content)
40
Ryu J.H., Colby T.V., Hartman T.E., Vassallo R.Smokingrelated interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122–132.
(check this in PDF content)
41
Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11–35, vii.
(check this in PDF content)
42
Vassallo R., Jensen E.A., Colby T.V. et al.The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.
(check this in PDF content)
43
Cottin V., Le Pavec J., Prevot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105–111.
(check this in PDF content)
44
Cottin V., Cordier J.F.The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1–2.
(check this in PDF content)
45
Cottin V., Nunes H., Brillet P.Y. et al.Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586–593.
(check this in PDF content)
46
Mejia M., Carrillo G., Rojas&Serrano J. et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10–15.
(check this in PDF content)
47
Akira M., Inoue Y., Kitaichi M. et al.Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271–279.
(check this in PDF content)
48
Flaherty K.R., Travis W.D., Colby T.V. et al.Histopathologic variability in usual and nonspecific interstitial 21 pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722–1727.
(check this in PDF content)
49
Flaherty K.R., Thwaite E.L., Kazerooni E.A. et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143–148.
(check this in PDF content)
50
Sverzellati N., Wells A.U., Tomassetti S. et al.Biopsyproved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957–964.
(check this in PDF content)
51
Sumikawa H., Johkoh T., Colby T.V. et al.Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433–439.
(check this in PDF content)
52
Silva C.I., Muller N.L., Hansell D.M. et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247: 251–259.
(check this in PDF content)
53
Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488–493.
(check this in PDF content)
54
Kim E.Y., Lee K.S., Chung M.P. et al.Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. Am. J. Roentgenol. 1999; 173: 949–953.
(check this in PDF content)
55
Hartman T.E., Swensen S.J., Hansell D.M. et al.Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701–705. [Published erratum appears in Radiology 218: 606.]
(check this in PDF content)
56
Park J.S., Lee K.S., Kim J.S. et al.Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645–648.
(check this in PDF content)
57
Cottin V., Donsbeck A.V., Revel D. et al. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med.1998; 158: 1286–1293.
(check this in PDF content)
58
Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia / fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010–1019.
(check this in PDF content)
59
Johkoh T., Muller N.L., Colby T.V. et al.Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: 199–204.
(check this in PDF content)
60
Johkoh T., Muller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555–560.
(check this in PDF content)
61
Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia / fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41–46.
(check this in PDF content)
62
MacDonald S.L., Rubens M.B., Hansell D.M. et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600–605.
(check this in PDF content)
63
Akira M., Inoue Y., Arai T. et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61–65.
(check this in PDF content)
64
Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia / fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136–147.
(check this in PDF content)
65
Travis W.D., Matsui K., Moss J., Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19–33.
(check this in PDF content)
66
Tsubamoto M., Muller N.L., Johkoh T. et al.Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J. Comput. Assist. Tomogr. 2005; 29: 793–800.
(check this in PDF content)
67
Park I.N., Jegal Y., Kim D.S. et al.Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68–76.
(check this in PDF content)
68
Hidalgo A., Franquet T., Gimenez A. et al. Smoking-related interstitial lung diseases: radiologic–pathologic correlation. Eur. Radiol. 2006; 16: 2463–2470.
(check this in PDF content)
69
Craig P.J., Wells A.U., Doffman S. et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275–282.
(check this in PDF content)
70
Fraig M., Shreesha U., Savici D., Katzenstein A.L. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am. J. Surg. Pathol. 2002; 26: 647–653.
(check this in PDF content)
71
Vassallo R., Ryu J.H. Tobacco smoke-related diffuse lung diseases. Semin. Respir. Crit. Care Med. 2008; 29: 643–650.
(check this in PDF content)
72
Portnoy J., Veraldi K.L., Schwarz M.I. et al. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007; 131: 664–671.
(check this in PDF content)
73
Doan M.L., Guillerman R.P., Dishop M.K. et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366–373.
(check this in PDF content)
74
Bullard J.E., Wert S.E., Whitsett J.A. et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026–1031.
(check this in PDF content)
75
Kawabata Y., Hoshi E., Murai K. et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707–714.
(check this in PDF content)
76
Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316–325.
(check this in PDF content)
77
Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am. Rev. Respir. Dis.1985; 132: 182–185.
(check this in PDF content)
78
King T.E., Mortenson R. Cryptogenic organizing pneumonitis: the North American experience. Chest 1992; 102(1, Suppl): 8S–13S.
(check this in PDF content)
79
Lee J.W., Lee K.S., Lee H.Y. et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. Am. J. Roentgenol. 2010; 195: 916–922.
(check this in PDF content)
80
Sen T., Udwadia Z.F. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India. J. Assoc. Physicians India 2008; 56: 229–232.
(check this in PDF content)
81
Oymak F.S., Demirbas H.M., Mavili E. et al. Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005; 72: 254–262.
(check this in PDF content)
82
Lee J.S., Lynch D.A., Sharma S. et al.Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J. Comput. Assist. Tomogr. 2003; 27: 260–265.
(check this in PDF content)
83
Lee K.S., Kullnig P., Hartman T.E., Muller N.L. Cryptogenic organizing pneumonia: CT findings in 43 patients. Am. J. Roentgenol. 1994; 162: 543–546.
(check this in PDF content)
84
Muller N.L., Staples C.A., Miller R.R. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am. J. Roentgenol. 1990; 154: 983–987.
(check this in PDF content)
85
Ujita M., Renzoni E.A., Veeraraghavan S. et al. Organizing pneumonia: perilobular pattern at thin–section CT. Radiology 2004; 232: 757–761.
(check this in PDF content)
86
Kim S.J., Lee K.S., Ryu Y.H. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am. J. Roentgenol. 2003; 180: 1251–1254.
(check this in PDF content)
87
Epler G.R., Colby T.V., McLoud T.C. et al. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152–158.
(check this in PDF content)
88
Lohr R.H., Boland B.J., Douglas W.W. et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 1997; 157: 1323–1329.
(check this in PDF content)
89
Lazor R., Vandevenne A., Pelletier A. et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am. J. Respir. Crit. Care Med. 2000; 162: 571–577.
(check this in PDF content)
90
Fischer A., Swigris J.J., du Bois R.M. et al.Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.
(check this in PDF content)
91
Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia. Eur. Respir. J. 2000; 15: 412–418.
(check this in PDF content)
92
Vourlekis J.S., Brown K.K., Cool C.D. et al.Acute interstitial pneumonitis: case series and review of the literature. Medicine (Baltimore) 2000; 79: 369–378.
(check this in PDF content)
93
Ichikado K., Suga M., Muller N.L. et al.Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am. J. Respir. Crit. Care Med. 2002; 165: 1551–1556.
(check this in PDF content)
94
Primack S.L., Hartman T.E., Ikezoe J. et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817–820.
(check this in PDF content)
95
Johkoh T., Muller N.L., Taniguchi H. et al.Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211: 859–863.
(check this in PDF content)
96
Desai S.R., Wells A.U., Rubens M.B. et al.Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210: 29–35.
(check this in PDF content)
97
Ichikado K., Suga M., Muranaka H. et al.Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 2006; 238: 321–329.
(check this in PDF content)
98
Araya J., Kawabata Y., Jinho P. et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008; 13: 408–412.
(check this in PDF content)
99
Rice A.J., Wells A.U., Bouros D. et al.Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am. J. Clin. Pathol. 2003; 119: 709–714.
(check this in PDF content)
100
Song J.W., Hong S.B., Lim C.M. et al.Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir. J. 2011; 37: 356–363.
(check this in PDF content)
101
Agarwal R., Jindal S.K.Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur. J. Intern. Med. 2008; 19: 227–235.
(check this in PDF content)
102
Silva C.I.S., Muller N.L., Fujimoto K. et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J. Thorac. Imag. 2007; 22: 221–229.
(check this in PDF content)
103
Churg A., Muller N.L., Silva C.I.S., Wright J.L. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol. 2007; 31: 277–284.
(check this in PDF content)
104
Suda T., Kaida Y., Nakamura Y. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846–853.
(check this in PDF content)
105
Park I.N., Kim D.S., Shim T.S. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214–220.
(check this in PDF content)
106
Miyazaki Y., Tateishi T., Akashi T. et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265–1270.
(check this in PDF content)
107
Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636–643.
(check this in PDF content)
108
Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 372–378.
(check this in PDF content)
109
Akira M., Hamada H., Sakatani M. et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 1997; 168: 79–83.
(check this in PDF content)
110
Fujimoto K., Taniguchi H., Johkoh T. et al.Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur. Radiol. 2012; 22: 83–92.
(check this in PDF content)
111
Cha S.I., Fessler M.B., Cool C.D. et al.Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 2006; 28: 364–369.
(check this in PDF content)
112
Johkoh T., Muller N.L., Pickford H.A. et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567–572.
(check this in PDF content)
113
Reddy T.L., Tominaga M., Hansell D.M. et al.Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40: 377–385.
(check this in PDF content)
114
Becker C.D., Gil J., Padilla M.L.Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod. Pathol. 2008; 21: 784–787.
(check this in PDF content)
115
Frankel S.K., Cool C.D., Lynch D.A., Brown K.K. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007–2013.
(check this in PDF content)
116
Thusen J.H., Hansell D.M., Tominaga M. et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod. Pathol. 2011; 24: 1633–1639.
(check this in PDF content)
117
Amitani R., Niimi A., Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF) [in Japanese]. Kokyu 1992; 11: 693–699.
(check this in PDF content)
118
Watanabe K., Nagata N., Kitasato Y. et al.Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir. Invest. 2012; 50: 88–97.
(check this in PDF content)
119
Beasley M.B., Franks T.J., Galvin J.R. et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch. Pathol. Lab. Med. 2002; 126: 1064–1070.
(check this in PDF content)
120
Balduin R., Giacometti C., Saccarola L. et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidos. Vasc. Diffuse Lung Dis. 2007; 24: 78–80.
(check this in PDF content)
121
Hariri L.P., Mino&Kenudson M., Shea B. et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum. Pathol. 2012; 43: 660–668.
(check this in PDF content)
122
Yokogawa N., Alcid D.V. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21: 2116–2117. 23
(check this in PDF content)
123
Churg A., Myers J., Suarez T. et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am. J. Surg. Pathol. 2004; 28: 62–68.
(check this in PDF content)
124
Fukuoka J., Franks T.J., Colby T.V. et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am. J. Surg. Pathol. 2005; 29: 948–954.
(check this in PDF content)
125
Yousem S.A., Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod. Pathol. 2002; 15: 1148–1153.
(check this in PDF content)
126
Mark E.J., Ruangchira Urai R.Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann. Diagn. Pathol. 2008; 12: 171–180.
(check this in PDF content)
127
Ryerson C.J., Urbania T.H., Richeldi L. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–757.
(check this in PDF content)
128
Kinder B.W., Brown K.K., McCormack F.X. et al.Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135: 1557–1563.
(check this in PDF content)
129
Satoh H., Kurishima K., Ishikawa H., Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J. Intern. Med. 2006; 260: 429–434.
(check this in PDF content)
130
Prasse A., Probst C., Bargagli E. et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717–723.
(check this in PDF content)
131
Prasse A., Pechkovsky D.V., Toews G.B. et al.CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthr. and Rheum. 2007; 56: 1685–1693.
(check this in PDF content)
132
Ishii H., Mukae H., Kadota J. et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57.
(check this in PDF content)
133
Ohnishi H., Yokoyama A., Kondo K. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 378–381.
(check this in PDF content)
134
Casoni G.L., Ulivi P., Mercatali L. et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int. J. Biol. Markers 2010; 25: 229–235.
(check this in PDF content)
135
Pignatti P., Brunetti G., Moretto D. et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 173: 310–317.
(check this in PDF content)
136
Ishii H., Mukae H., Kadota J. et al.Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39–45.
(check this in PDF content)
137
Choi E.S., Pierce E.M., Jakubzick C. et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 2006; 59: 28–39.
(check this in PDF content)
138
Choi E.S., Jakubzick C., Carpenter K.J. et al.Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2004; 170: 508–515.
(check this in PDF content)
139
Yang I.V., Burch L.H., Steele M.P. et al.Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 45–54.
(check this in PDF content)
140
Lawson W.E., Grant S.W., Ambrosini V. et al.Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977–980.
(check this in PDF content)
141
Kim K.K., Flaherty K.R., Long Q. et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 2003; 9: 52–56.
(check this in PDF content)
142
Markart P., Ruppert C., Wygrecka M. et al.Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 2007; 29: 134–137.
(check this in PDF content)
143
Zorzetto M., Ferrarotti I., Campo I. et al. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2005; 22: 180–185.
(check this in PDF content)
144
Hutyrova B., Pantelidis P., Drabek J. et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 148–151.
(check this in PDF content)
145
Renzoni E., Lympany P., Sestini P. et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthr. and Rheum. 2000; 43: 1633–1640.
(check this in PDF content)
146
Zorzetto M., Ferrarotti I., Trisolini R. et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 330–334.
(check this in PDF content)
147
Hodgson U., Tukiainen P., Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir. Med. 2005; 99: 265–267.
(check this in PDF content)
148
Kubistova Z., Mrazek F., Lympany P.A. et al.The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72: 483–486.
(check this in PDF content)
149
Mushiroda T., Wattanapokayakit S., Takahashi A. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654–656.
(check this in PDF content)
150
Selman M., Lin H.&M., Montaño M. et al.Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 2003; 113: 542-550.
(check this in PDF content)
151
Falfán&Valencia R., Camarena A., Juárez A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 2005; 118: 235–244.
(check this in PDF content)
152
Checa M., Ruiz V., Montaño M. et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465–472.
(check this in PDF content)
153
Matsushima H., Takayanagi N., Sakamoto T. et al. Pathologic findings both before and after steroid therapy in a case of desquamative interstitial pneumonia [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39: 609–614.
(check this in PDF content)
154
Latsi P.I., du Bois R.M., Nicholson A.G. et al.Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.2003; 168: 531–537.
(check this in PDF content)
155
Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.
(check this in PDF content)
156
Greene K.E., King T.E., Kuroki Y. et al.Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.
(check this in PDF content)
157
Yokoyama A., Kondo K., Nakajima M. et al.Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.
(check this in PDF content)
158
Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.
(check this in PDF content)
159
Daniil Z.D., Papageorgiou E., Koutsokera A. et al.Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.
(check this in PDF content)
160
Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.
(check this in PDF content)
161
Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.
(check this in PDF content)
162
Richards T.J., Kaminski N., Baribaud F. et al.Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.
(check this in PDF content)
163
McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.
(check this in PDF content)
164
Shinoda H., Tasaka S., Fujishima S. et al.Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.
(check this in PDF content)
165
Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161. Поступила 12.11.13 УДК 616.24!002
(check this in PDF content)